One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2021-147465
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 3 |
Affiliation: University Hospital Ulm, The Alfred Hospital, Cornell University, NewYork–Presbyterian Hospital, Hospital Universitari i Politècnic La Fe, Hochschule Hannover, Hannover Medical School, The University of Texas MD Anderson Cancer Center, Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris, Université Paris Cité, University of Helsinki, Helsinki University Hospital, University of Alberta, University of Kansas Medical Center, University Medical Center, University Hospital and Clinics, Bristol-Myers Squibb (United States)
Prognostic Impact of NPM1 and FLT3 Mutations at Diagnosis and Presence of Measurable Residual Disease (MRD) after Intensive Chemotherapy (IC) for Patients with Acute Myeloid Leukemia (AML) in Remission: Outcomes from the QUAZAR AML-001 Trial of Oral Azacitidine (Oral-AZA) Maintenance
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
